−158
Aurinia Pharmaceuticals Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−79.5
FY23:
−33.5
FY24:
44.4
FY25:
136
Change from FY21 to FY25
millions USD
FY21:
−104
FY22:
−60.6
FY23:
−6.71
FY24:
39.3
FY25:
−32.8
Change from FY21 to FY25
millions USD
FY21:
221
FY22:
2.43
FY23:
−5.13
FY24:
−49.1
FY25:
−106
millions USD
FY21:
−40.5
FY22:
−138
FY23:
−45.3
FY24:
34.6
FY25:
−3.22
All amounts in millions USD